Netherlands· NL-bb7c8081082b
Salbutamol Noridem 2,5 mg/2,5 ml verneveloplossing
A salbutamol product containing salbutamolsulfaat, registered in Netherlands by Noridem Enterprises Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Salbutamol is registered in 13 of 19 countries.
Countries holding a registration under ATC R03AC02 (salbutamol), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Salbutamol · ATC R03AC02
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of salbutamol costs, country by country.
Normalised to the WHO defined daily dose (0.8 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Salbutamol · price per daily dose (0.8 mg)
USD · FX 28 Sept 2026
- ES Spain$0.096
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- SALBUTAMOLSULFAAT
- Manufacturer
- Noridem Enterprises Ltd
- Country
- Netherlands (NL)
- ATC code
- R03AC02
- ATC class
- Salbutamol
- Defined daily dose
- 0.8 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id134890
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
915 interactions on record for salbutamol.
Graded by severity as the source publishes them — 24 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Salbutamol · interactions on record
915 records
- 24 severe
- 427 moderate
- 27 minor
- 436 info
Most severe, free to view
- PapaverineA03AD01severe
- PapaverinC04AX38severe
- PindololC07AA03severe
- PropranololC07AA05severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Salbutamol in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceSALBUTAMOL ARROW 2,5 mg/2,5 mL, solution pour inhalation par nébuliseur en récipient unidoseARROW GENERIQUES
- NorwaySalbuairLaboratorio Aldo-Unión
- IrelandBrodilaten 2.5 mg/2.5 ml nebuliser solutionNoridem Enterprises Limited
- FinlandSalbutamol NeutecNeutec Inhaler Ireland Limited
- BelgiumSalbutamol Teva Pharma 2,5 mg/2,5 mlTeva Pharma
- SwedenAiromir 1 mg/ml Lösning för nebulisatorTeva Sweden AB
- IcelandVentolineGlaxoSmithKline Pharma A/S
- PolandVentolinDelfarma Sp. z o.o.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Novolizer Salbutamol Meda, Salbutamol Glenmark
- Belgium · Airomir, Airomir Autohaler
- Bulgaria · Buto-Asma, Вентолин
- Cyprus · Brodilaten Noridem Enterprises, Medolin
- Czechia · Buventol Easyhaler, Ecosal Inhaler
- Germany · Apsomol N Für Erwachsene Und Kinder Ab 4 Jahren, Bronchospray Autohaler
- Denmark · Airomir, Airsalb
- Estonia · Buventol Easyhaler, Ventolin
- Spain · Aldobronquial, Salbuair
- Finland · Airomir, Airomir Autohaler
- France · Airomir Autohaler, Salbumol
- United Kingdom (Northern Ireland) · Airomir Inhaler, Airsalb
- Greece · Aerolin, Asthmotrat
- Croatia · Antamenys, Salbutamol Pliva
- Hungary · Buventol Easyhaler, Ventolin Evohaler
- Ireland · Brodilaten, Salamol
- Iceland · Salbutamol Neutec, Ventoline
- Italy · Broncovaleas, Salbutamol Noridem
- Lithuania · Salbutamol Inteli, Ventolin
- Luxembourg · Airomir, Airomir Autohaler
- Latvia · Salbutamol Inteli, Ventolin
- Malta · Ventoaldo, Ventolin
- Norway · Airomir, Airomir Autohaler
- Poland · Aspulmo, Buventol Easyhaler
- Portugal · Salbutamol Gp, Salbutamol Noridem
- Romania · Salbutamol, Salbutamol Eipico
- Sweden · Airomir, Airomir Autohaler
- Slovenia · Antamenys, Ventolin
- Slovakia · Salbutamol Noridem, Ventolin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4cccc3f7-3209-4437-a067-20a7d1e3192c GET /v1/drugs/4cccc3f7-3209-4437-a067-20a7d1e3192c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Verneveloplossing",
"route": "Inhalatie",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h134890_smpc.pdf",
"strength": null,
"atc_label": "Salbutamol",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg134890",
"excipients": [
"NATRIUMCHLORIDE",
"STIKSTOF (E 941)",
"WATER VOOR INJECTIE",
"ZWAVELZUUR (E 513)"
],
"substances": [
"SALBUTAMOLSULFAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h134890.pdf",
"authorised_at": "2026/01/14",
"procedure_number": "IE/H/0713/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "134890",
"additional_monitoring": "N"
}See everything about salbutamol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.